Skip to main content
. Author manuscript; available in PMC: 2025 Aug 1.
Published in final edited form as: J Clin Pharmacol. 2024 Mar 28;64(8):963–974. doi: 10.1002/jcph.2434

Table 1.

Demographics of the POP01 external evaluation data set. PNA: Postnatal age

Variable Median (Range) or N (%)
PNA <2 years PNA ≥ 2 to ≤ 8 years PNA >8 years Total
N 41 26 35 102
Postnatal age (years) 0.35 (0.01–1.86) 4.56 (2.07–7.93) 14.4 (8.34–19.9) 3.61 (0.01–19.9)
Postmenstrual agea (weeks) 58.3 (37.7–137) 277 (148–454) 793 (473–1080) 226 (37.7–1080)
Body weight (kg) 5.70 (2.66–12.8) 17.27 (9.20–33.0) 55.0 (24.0–112) 16.3 (2.66–112)
Body mass index (kg/m2) 15.7 (10.9–25.1) 15.9 (13.5–25.4) 23.4 (13.8–38.6) 17.8 (10.9–38.6)
Body mass index percentile NAb 57.9 (4.68–99.2) 88.2 (0.05–99.6) 78.5 (0.05–99.6)
Female 20 (48.8) 12 (46.2) 15 (42.9) 47 (46.1)
Serum Creatinine (mg/dL) 0.3 (0.1–1.0) 0.44 (0.19–2.30) 0.60 (0.1–1.95) 0.41 (0.1–2.30)
Serum Albumin (g/dL) 2.8 (2.0–4.1) 3.2 (2.0–5.3) 2.8 (1.5–4.6) 2.9 (1.5–5.3)
Race
 White 31 (75.6) 20 (76.9) 25 (71.4) 76 (74.5)
 Black or African American 7 (17.1) 2 (7.7) 7 (20) 16 (15.7)
 Asian 1 (2.4) 1 (3.8) 1 (2.9) 3 (2.9)
 Native American 0 (0) 0 (0) 1 (2.9) 1 (1.0)
 Unknown or not reportedc 2 (4.8) 3 (11.5) 1 (2.9) 6 (5.8)
 Ethnicity
 Hispanic or Latino 5 (12.2) 2 (7.7) 1 (2.9) 8 (7.8)
 Not Hispanic or Latino 36 (87.8) 24 (92.3) 34 (97.1) 94 (92.2)
Obese Statusd
 With Obesity NAb 6 (23.1) 11 (31.4) 17 (16.7)
Had Surgerye
 Yes 10 (24.4) 5 (19.2) 7 (20.0) 22 (21.6)
a

Postmenstrual age was calculated as PNA + 40 weeks when GA was missing

b

Body mass index percentile is not available for patients <2 years of age

c

Includes individuals listed as ‘mixed race’

d

Obesity defined by BMI > 95th percentile for age and sex (body mass index percentile > 95)

e

Reported as surgery occurring within 24h prior to the first dose of dexmedetomidine